Advair HFA 230/21mcg Oral Inh 120s

Manufacturer GLAXO SMITH KLINE Active Ingredient Fluticasone and Salmeterol Inhaler(floo TIK a sone & sal ME te role) Pronunciation AD-vair H-F-A (floo-TIK-a-sone & sal-ME-te-role)
It is used to treat asthma.Do not use this drug to treat intense flare-ups of shortness of breath. Use a rescue inhaler. If you have questions, talk with the doctor.
đŸˇī¸
Drug Class
Bronchodilator/Corticosteroid Combination
đŸ§Ŧ
Pharmacologic Class
Inhaled Corticosteroid (ICS) / Long-Acting Beta2-Adrenergic Agonist (LABA)
🤰
Pregnancy Category
Not available
✅
FDA Approved
Aug 2006
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Advair HFA is an inhaler that contains two medicines: fluticasone and salmeterol. Fluticasone is a steroid that helps reduce inflammation in your lungs, making it easier to breathe. Salmeterol is a long-acting bronchodilator that helps relax the muscles around your airways, keeping them open for a longer time. This medicine is used to help prevent asthma attacks and improve breathing, but it is not for sudden breathing problems.
📋

How to Use This Medicine

Taking Your Medication Correctly

To use this medication safely and effectively, follow your doctor's instructions and the information provided below.

Use your inhaler only for breathing in, as directed by your doctor or healthcare provider.
Continue using this medication even if you feel well, and take it at the same time every day.
After each use, rinse your mouth with water, then spit it out - do not swallow the rinse water.
If you are using multiple inhaled medications, consult your doctor about which one to use first.
Before using your inhaler, shake it well.
Before the first use, prime your inhaler by spraying 4 test sprays into the air, away from your face. If your inhaler has not been used for more than 4 weeks or has been dropped, prime it again with 2 sprays into the air, away from your face, shaking well before each test spray.
Replace the cap on your inhaler after each use.
Be cautious when using your inhaler, as it may be flammable - keep it away from open flames and do not use it while smoking.

Storing and Disposing of Your Medication

Store your inhaler at room temperature in a dry place, avoiding bathrooms.
Keep your inhaler stored with the mouthpiece down.
If your inhaler has a dose counter, dispose of it when the counter reaches "0".

Missing a Dose

If you miss a dose, skip it and return to your regular schedule.
* Do not take two doses at the same time or take extra doses.
💡

Lifestyle & Tips

  • Use your inhaler regularly, twice a day, every day, even if you feel well. Do not stop using it without talking to your doctor.
  • Rinse your mouth with water and spit it out after each use of Advair HFA to help prevent a yeast infection (thrush) in your mouth and throat.
  • Always have a fast-acting rescue inhaler (like albuterol) with you for sudden asthma symptoms.
  • Do not use Advair HFA for sudden, severe breathing problems.
  • Keep track of your asthma symptoms and how often you use your rescue inhaler.
  • Avoid triggers that worsen your asthma (e.g., smoke, allergens, cold air).
  • Maintain good hydration and a healthy lifestyle.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 2 inhalations (fluticasone 230 mcg/salmeterol 21 mcg) twice daily, approximately 12 hours apart

Condition-Specific Dosing:

asthma: 2 inhalations (fluticasone 230 mcg/salmeterol 21 mcg) twice daily
COPD: Not indicated for COPD with this strength (Advair HFA 230/21 is for asthma only). Advair Diskus has COPD indication for other strengths.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for this strength (Advair HFA 230/21 mcg). Lower strengths (45/21 mcg, 115/21 mcg) are approved for children 12 years and older for asthma.
Adolescent: For asthma in adolescents 12 years and older: 2 inhalations (fluticasone 45 mcg/salmeterol 21 mcg) or (fluticasone 115 mcg/salmeterol 21 mcg) twice daily. The 230/21 mcg strength is generally reserved for patients requiring higher doses of ICS.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment necessary
Moderate: No dosage adjustment necessary
Severe: No dosage adjustment necessary
Dialysis: No specific recommendations; systemic exposure is low.

Hepatic Impairment:

Mild: No dosage adjustment necessary
Moderate: Use with caution; monitor for systemic corticosteroid effects.
Severe: Use with caution; monitor for systemic corticosteroid effects. Fluticasone and salmeterol are primarily cleared by hepatic metabolism.
Confidence: Medium

Pharmacology

đŸ”Ŧ

Mechanism of Action

Fluticasone propionate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity. It reduces inflammation in the airways, decreasing bronchial hyperresponsiveness. Salmeterol xinafoate is a long-acting beta2-adrenergic agonist (LABA) that selectively stimulates beta2-adrenergic receptors in the lungs, leading to relaxation of bronchial smooth muscle and bronchodilation. The combination provides both anti-inflammatory and bronchodilator effects.
📊

Pharmacokinetics

Absorption:

Bioavailability: Fluticasone: ~1% (oral), ~30% (inhaled, systemic). Salmeterol: Low systemic bioavailability due to extensive first-pass metabolism.
Tmax: Fluticasone: 0.5-1 hour (inhaled). Salmeterol: 5-10 minutes (inhaled).
FoodEffect: Not applicable for inhaled administration.

Distribution:

Vd: Fluticasone: ~318 L. Salmeterol: ~156 L.
ProteinBinding: Fluticasone: >90%. Salmeterol: ~96%.
CnssPenetration: Limited for both components due to high protein binding and low systemic exposure.

Elimination:

HalfLife: Fluticasone: ~8 hours (terminal). Salmeterol: ~5.5 hours (terminal).
Clearance: Fluticasone: ~1150 mL/min. Salmeterol: ~1200 mL/min.
ExcretionRoute: Fluticasone: Primarily feces (as metabolites). Salmeterol: Primarily feces (~60%) and urine (~25%) as metabolites.
Unchanged: Fluticasone: <5% in urine. Salmeterol: <5% in urine.
âąī¸

Pharmacodynamics

OnsetOfAction: Salmeterol: 10-20 minutes (significant bronchodilation). Fluticasone: Days to weeks for full anti-inflammatory effect.
PeakEffect: Salmeterol: 2-4 hours. Fluticasone: 1-2 weeks.
DurationOfAction: Salmeterol: 12 hours. Fluticasone: Sustained anti-inflammatory effect with twice-daily dosing.
Confidence: Medium

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Long-acting beta2-adrenergic agonists (LABAs), such as salmeterol, increase the risk of asthma-related death. Data from a large, randomized, placebo-controlled clinical trial in asthma (Salmeterol Multicenter Asthma Research Trial [SMART]) showed an increase in asthma-related deaths in patients receiving salmeterol. This finding is considered a class effect of LABAs. Therefore, Advair HFA is not indicated for the primary treatment of status asthmaticus or other acute episodes of asthma or COPD where intensive measures are required. Advair HFA should only be used in patients with asthma who are currently receiving but are inadequately controlled on a long-term asthma control medication, such as an inhaled corticosteroid, or whose disease severity clearly warrants initiation of treatment with both an inhaled corticosteroid and a LABA. Once asthma control is achieved and maintained, assess the patient at regular intervals and, if appropriate, step down therapy (e.g., discontinue Advair HFA) while maintaining asthma control with an inhaled corticosteroid. Do not use Advair HFA for patients whose asthma is adequately controlled on low- or medium-dose inhaled corticosteroids.
âš ī¸

Side Effects

Serious Side Effects: Seek Medical Help Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention right away:

Signs of an allergic reaction: rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, difficulty breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat
Signs of infection: fever, chills, severe sore throat, ear or sinus pain, cough, increased or changed sputum production, painful urination, mouth sores, or a wound that won't heal
Signs of high blood sugar: confusion, drowsiness, excessive thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath
Signs of low potassium levels: muscle pain or weakness, muscle cramps, or an irregular heartbeat
Signs of a weak adrenal gland: severe nausea or vomiting, extreme dizziness or fainting, muscle weakness, fatigue, mood changes, decreased appetite, or weight loss
Signs of high or low blood pressure: severe headache or dizziness, fainting, or changes in vision
Chest pain or pressure
Rapid or abnormal heartbeat
Shakiness
Feeling nervous or agitated
Changes in behavior
Vision changes, eye pain, or severe eye irritation
Burning, numbness, or tingling sensations
Choking
Voice changes
Seizures
Bone pain
Sleep disturbances
Feeling extremely tired or weak
Vaginal itching or discharge
Weight gain
Mouth irritation or mouth sores
Redness or white patches in the mouth or throat

Important Warning: This medication can cause severe breathing problems, which may be life-threatening. If you experience difficulty breathing, worsening breathing, wheezing, or coughing after taking this medication, use a rescue inhaler and seek medical help immediately.

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to contact your doctor or seek medical help if you notice any of the following:

Headache
Upset stomach or vomiting
Throat irritation
* Common cold symptoms

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening asthma symptoms (e.g., increased wheezing, shortness of breath, cough)
  • Increased need for your rescue inhaler
  • Signs of an allergic reaction (e.g., rash, hives, swelling of face/mouth/tongue, severe dizziness, trouble breathing)
  • Chest pain or fast/pounding heartbeat
  • Tremor or nervousness
  • Signs of infection (e.g., fever, chills, increased mucus, change in mucus color)
  • Oral thrush (white patches in mouth/throat)
  • Vision changes (e.g., blurred vision, eye pain)
  • Unusual tiredness or weakness
  • Muscle cramps or weakness
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the symptoms you experienced.
If you are currently using a similar medication. If you are unsure, consult your doctor or pharmacist for clarification.
Any prescription or over-the-counter medications, natural products, or vitamins you are taking that may interact with this medication. Certain medications used to treat HIV, infections, depression, and other conditions should not be taken with this drug. Your doctor or pharmacist can advise you on potential interactions.
Note that this is not an exhaustive list of all medications or health conditions that may interact with this drug.

To ensure your safety, it is crucial to:

Inform your doctor and pharmacist about all your medications (prescription or over-the-counter), natural products, vitamins, and health conditions.
Verify that it is safe to take this medication with your existing medications and health conditions.
* Do not start, stop, or change the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

Important Information About Your Medication

It is crucial that you inform all of your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. You may not feel the full effects of this drug for about 1 week.

Special Considerations

If you have diabetes (high blood sugar), discuss this with your doctor, as this medication may increase your blood sugar levels. Monitor your breathing problems closely, and contact your doctor immediately if they worsen, if your rescue inhaler is not effective, or if you need to use it more frequently.

Safe Use

Do not exceed the recommended dose or frequency of this medication. Taking too much of this type of drug can be fatal. Consult your doctor if you have any questions or concerns.

Transitioning from Oral Steroids

When switching from an oral steroid to another form of steroid, you may be at risk for severe and potentially life-threatening side effects. Be aware of symptoms such as weakness, fatigue, dizziness, nausea, vomiting, confusion, or low blood sugar, and contact your doctor immediately if you experience any of these.

In the event of a severe injury, surgery, or infection, you may require additional doses of oral steroids to help your body cope with the stress. Carry a warning card with you to alert healthcare providers of this potential need.

Long-term Use and Potential Risks

Prolonged use of this medication may increase your risk of developing cataracts or glaucoma. Discuss this with your doctor and schedule regular eye exams as recommended.

Long-term use may also lead to weak bones (osteoporosis). Consult your doctor to determine if you are at higher risk or have any questions. Have a bone density test as advised by your doctor.

Infection Risk

You may be more susceptible to infections while taking this medication. To minimize this risk, wash your hands frequently and avoid close contact with people who have infections, colds, or flu.

If you have not had chickenpox or measles before, avoid exposure to these illnesses, as they can be severe or even fatal in people taking steroid medications like this one. If you have been exposed, contact your doctor immediately.

Special Populations

If you are 65 or older, use this medication with caution, as you may be more prone to side effects.

In children and teenagers, this medication may affect growth in some cases. Regular growth checks may be necessary. Discuss this with your doctor.

Pregnancy and Breastfeeding

If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor. You will need to discuss the potential benefits and risks of this medication to you and your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Chest pain
  • Fast or irregular heartbeat
  • Tremor
  • Nervousness
  • Headache
  • Dizziness
  • Nausea
  • Vomiting
  • Muscle cramps
  • Seizures
  • Hypokalemia (low potassium)
  • Hyperglycemia (high blood sugar)
  • Signs of hypercorticism (e.g., Cushingoid features, adrenal suppression) with chronic overdose

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Treatment is supportive and symptomatic. Monitor cardiac function (ECG), serum potassium, and blood glucose levels.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole, clarithromycin, telithromycin, nefazodone) due to increased systemic exposure to fluticasone and salmeterol, leading to increased risk of cardiovascular and systemic corticosteroid effects.
🔴

Major Interactions

  • Beta-blockers (non-cardioselective): May block the bronchodilatory effect of salmeterol and cause severe bronchospasm, especially in patients with asthma. Use with caution, consider cardioselective beta-blockers if necessary.
  • Other long-acting beta2-agonists (LABAs): Concomitant use is not recommended due to increased risk of adverse cardiovascular effects.
  • Diuretics (loop or thiazide): May potentiate ECG changes and/or hypokalemia associated with beta-agonists, especially at high doses.
  • Tricyclic antidepressants (TCAs) and Monoamine Oxidase Inhibitors (MAOIs): May potentiate the cardiovascular effects of salmeterol (e.g., arrhythmias, hypertension). Use with extreme caution or avoid within 2 weeks of discontinuing MAOIs.
🟡

Moderate Interactions

  • Moderate CYP3A4 inhibitors (e.g., erythromycin, diltiazem, verapamil, grapefruit juice): May increase systemic exposure to fluticasone and salmeterol. Use with caution.
  • Sympathomimetics: Concomitant use may potentiate cardiovascular effects.
  • Xanthine derivatives (e.g., theophylline): May potentiate hypokalemia and cardiovascular effects.
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Pulmonary Function Tests (e.g., FEV1)

Rationale: To establish baseline lung function and assess disease severity.

Timing: Prior to initiation of therapy.

Asthma Control Assessment (e.g., ACT score)

Rationale: To establish baseline symptom control and quality of life.

Timing: Prior to initiation of therapy.

Medical History (including cardiovascular disease, diabetes, glaucoma, cataracts, osteoporosis)

Rationale: To identify pre-existing conditions that may be exacerbated or require closer monitoring.

Timing: Prior to initiation of therapy.

📊

Routine Monitoring

Asthma Symptoms and Exacerbation Frequency

Frequency: Regularly (e.g., daily symptom diary, monthly review)

Target: Well-controlled asthma (minimal symptoms, no nocturnal awakenings, minimal rescue inhaler use)

Action Threshold: Increasing symptoms, increased rescue inhaler use, nocturnal awakenings, decreased peak flow readings.

Pulmonary Function Tests (FEV1)

Frequency: Periodically (e.g., every 3-12 months, or as clinically indicated)

Target: Maintain or improve baseline FEV1

Action Threshold: Significant decline in FEV1.

Growth (in pediatric patients)

Frequency: Annually

Target: Normal growth velocity

Action Threshold: Growth retardation.

Ocular Examination (for glaucoma/cataracts)

Frequency: Periodically, especially in patients with risk factors or long-term use.

Target: Normal intraocular pressure, absence of cataracts.

Action Threshold: Increased intraocular pressure, development of cataracts.

Bone Mineral Density (BMD)

Frequency: Consider periodically in patients at risk for osteoporosis with long-term use.

Target: Maintain BMD

Action Threshold: Significant bone loss.

Serum Potassium and Glucose

Frequency: Periodically, especially in patients with risk factors for hypokalemia or hyperglycemia.

Target: Normal ranges

Action Threshold: Significant deviations from normal.

đŸ‘ī¸

Symptom Monitoring

  • Increased wheezing
  • Shortness of breath
  • Chest tightness
  • Increased cough
  • Increased need for rescue inhaler
  • Nocturnal awakenings due to asthma
  • Signs of oral candidiasis (thrush)
  • Signs of systemic corticosteroid effects (e.g., easy bruising, moon face, weight gain)
  • Palpitations
  • Tremor
  • Muscle cramps

Special Patient Groups

🤰

Pregnancy

Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Asthma control is important during pregnancy, as poorly controlled asthma can lead to adverse maternal and fetal outcomes. There are no adequate and well-controlled studies of Advair HFA in pregnant women. Animal studies have shown teratogenic effects with high doses of fluticasone and salmeterol.

Trimester-Specific Risks:

First Trimester: Potential for teratogenic effects observed in animal studies at high doses. Systemic exposure is low with inhaled use.
Second Trimester: Continued need for asthma control. Monitor for systemic corticosteroid effects.
Third Trimester: Continued need for asthma control. Monitor for systemic corticosteroid effects. Potential for transient hypoadrenalism in neonates born to mothers receiving high doses of corticosteroids.
🤱

Lactation

Caution should be exercised when Advair HFA is administered to a nursing mother. It is not known whether fluticasone or salmeterol are excreted in human milk. However, other corticosteroids and beta2-agonists are excreted in human milk. The benefits of breastfeeding should be weighed against the potential risks.

Infant Risk: L3 (Moderate risk) - Due to potential for systemic absorption and excretion into breast milk, though levels are likely low with inhaled administration. Monitor infant for signs of systemic corticosteroid effects or beta-agonist effects (e.g., irritability, poor feeding).
đŸ‘ļ

Pediatric Use

Advair HFA 230/21 mcg is not approved for pediatric patients under 12 years of age. Lower strengths (45/21 mcg, 115/21 mcg) are approved for asthma in children 12 years and older. Monitor growth velocity in pediatric patients receiving inhaled corticosteroids, as they may cause a reduction in growth rate. The lowest effective dose should be used.

👴

Geriatric Use

No overall differences in safety or effectiveness have been observed between elderly and younger patients. However, caution should be exercised in elderly patients with concomitant cardiovascular disease or other conditions that may be exacerbated by beta-agonists.

Clinical Information

💎

Clinical Pearls

  • Advair HFA is a maintenance inhaler and should be used regularly, twice daily, not for acute asthma attacks. Patients should always carry a rescue inhaler.
  • Proper inhaler technique is crucial for effective delivery of the medication. Educate patients on how to use the HFA inhaler correctly, including shaking before each spray, slow deep inhalation, and breath-holding.
  • Rinsing the mouth and spitting out water after each dose helps prevent oral candidiasis (thrush).
  • Patients should be advised not to exceed the prescribed dose or use other LABA-containing products.
  • Monitor for signs of systemic corticosteroid effects, especially with long-term use or higher doses, such as adrenal suppression, bone mineral density loss, and ocular effects (glaucoma, cataracts).
  • The black box warning regarding increased risk of asthma-related death with LABAs should be discussed with patients. Advair HFA should only be used when an ICS alone is insufficient.
  • Patients should be instructed to contact their healthcare provider if their asthma symptoms worsen or if their rescue inhaler use increases.
🔄

Alternative Therapies

  • Inhaled Corticosteroids (ICS) monotherapy (e.g., fluticasone propionate, budesonide, mometasone, beclomethasone, ciclesonide)
  • Leukotriene Receptor Antagonists (LTRAs) (e.g., montelukast)
  • Long-Acting Muscarinic Antagonists (LAMAs) (e.g., tiotropium, umeclidinium) - generally for COPD, but tiotropium can be add-on for severe asthma.
  • Oral Corticosteroids (for severe exacerbations or refractory asthma)
  • Biologic therapies (e.g., omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab) for severe asthma.
💰

Cost & Coverage

Average Cost: Varies widely, typically $300-$500+ per 120 actuations inhaler
Generic Available: Yes
Insurance Coverage: Tier 2 or Tier 3 (preferred or non-preferred brand), some generics may be Tier 1 or 2.
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more details. If you have any questions or concerns about this medication, don't hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide information about the medication taken, the amount, and the time it occurred.